Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Apr 29, 2024

Sun Pharma Faces Rs 1.11 Crore Tax Demand Over Disallowed Input Tax Credit

Sun Pharma Faces Rs 1.11 Crore Tax Demand Over Disallowed Input Tax Credit
File photo (Sun Pharmaceutical Industries/Facebook)
STOCKS IN THIS STORY
Sun Pharmaceutical Industries Ltd.
--
Nifty MidSmall India Consumption
--

Sun Pharmaceutical Industries Ltd on Monday said it has received a tax demand of over Rs 1.11 crore from authorities over disallowed input tax credit.

The company has received an order from the Joint Commissioner, CGST and Central Excise, passed under the GST Act, raising a demand of Rs 1,11,60,156, imposing a penalty of Rs 11,16,016 and interest as applicable, Sun Pharmaceutical Industries said in a regulatory filing.

The reason for the order is disallowed input tax credit on account of inadmissible transitional credit, it added.

"There is no material impact on financial, operation or other activities of the company," the filing said.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search